Consistent with the hypothesis that BDNF increases AMPAR trafficking to the glioma cell membrane, BDNF exposure increased glioma cell surface levels of the AMPAR subunits GluA3 and GluA4 compared with vehicle-treated control glioma cells (Fig. 3b–e). The gene discussed is BDNF; the disease is central nervous system cancer.